Crossmark

5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia

Crossref DOI link: https://doi.org/10.1016/j.acuroe.2018.05.013

Published Print: 2019-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Alcántara Montero, A.

Müller-Arteaga, C.
License Information

Text and Data Mining valid from 2019-01-01
More Information

This article is maintained by: Elsevier

Article Title: 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia

Journal Title: Actas Urológicas Españolas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.acuroe.2018.05.013

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.acuro.2018.05.003

Content Type: simple-article

Copyright: © 2018 AEU. Published by Elsevier España, S.L.U. All rights reserved.